Clinical Trial Update: Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing NN5401 plus insulin aspart versus insulin detemir plus insulin aspart in adults with Type 1 diabetes; results have been posted followi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• Insulin detemir (insulin detemir)
• NN5401

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-20